By Peggy Peck, Executive Editor, MedPage Today
Published: August 01, 2008
Reviewed by Zalman S. Agus, MD; Emeritus Professor
University of Pennsylvania School of Medicine.
CHICAGO, Aug. 1 -- Dementia patients who persistently took medication for the condition had increased median survival by about three years, but it is unknown if the drugs were associated with delayed institutionalization, researchers here reported
Action Points
--------------------------------------------------------------------------------
Explain to interested patients that this report describes observational findings that suggest an association between treatment with approved antidementia drugs and overall survival, which includes survival in nursing homes.
Note that this study was published as an abstract and presented as a poster at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.
click here to
read the full article
MedPage Today CMES for healthcare professionals
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment